Advisors Preferred’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Advisors Preferred's NVS Position: Q2 2026 in Review
Advisors Preferred reduced its Novartis (NVS) stake by 75% in Q2 2026, selling an estimated $297K and leaving 664 shares worth $106K. The position accounts for 0.02% of the portfolio, ranked #188.
Advisors Preferred first reported a position in NVS in Q1 2014 and has held it in 8 quarters since. The position peaked at $404K in Q1 2026. 1,621 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Advisors Preferred held 664 shares of Novartis worth $106K as of Q2 2026.
- Advisors Preferred sold 1,981 Novartis shares in Q2 2026, an estimated $297K.
- Novartis made up 0.02% of Advisors Preferred's portfolio in Q2 2026, its #188 holding.
- Advisors Preferred first reported a position in Novartis in Q1 2014 and has held it in 8 quarters since.
- Advisors Preferred's Novartis position peaked at $404K in Q1 2026.
- 1,621 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Advisors Preferred's 13F filing for Q2 2026, filed 11 Aug 2026.